Our Site was invited to participate in a new clinical trial of a new medicine for the biological therapy of severe eosinophilic bronchial asthma, conducted by the pharmaceutical company GSK.
Our Site was invited to participate in a new clinical trial of a new medicine for the biological therapy of severe eosinophilic bronchial asthma, conducted by the pharmaceutical company GSK.